Leerink Partners Remains Bullish on Zimmer Biomet Holdings (ZBH) Following an In-Line 3Q
Leerink Partners maintained an Outperform rating on Zimmer Holdings (NYSE: ZBH), and cut the price target to $125.00 (from $130.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
